Why the study?
Do intravenous calcium antagonists alter systemic capacitance vessels and venous return in anesthetized dogs?
Do intravenous calcium antagonists alter systemic capacitance vessels and venous return in anesthetized dogs?
Calcium antagonists decrease resistance to venous return and increase venous return in dogs, with varying effects on systemic capacitance vessels depending on the specific agent and sympathetic tone.
Answers are grounded in this paper and cite their sources.
These canine results should not change practice; leaves open translation of calcium antagonist effects on venous return to humans.
We measured mean circulatory pressure (MCP) in anesthetized, open-chest dogs before and after intravenous administration of Ca++-antagonists to estimate the effects on systemic capacitance vessels and on venous return (VR) curves both with and without continuous intravenous infusion of norepinephrine (NE). Diltiazem (300 micrograms/kg) decreased total peripheral resistance (TPR) and MCP significantly. Nifedipine (5 micrograms/kg), nicardipine (30 micrograms/kg) and verapamil (200 micrograms/kg) decreased TPR significantly without any change in MCP in the absence of NE, but with the exception of verapamil, they decreased MCP in the presence of NE. This indicates that diltiazem relaxed the systemic capacitance vessels, and nifedipine and nicardipine significantly decreased the tone of the systemic capacitance vessels that had been previously elevated by NE, but this action was very slight with verapamil. These Ca++-antagonists rotated VR curves clockwise, decreased resistance to VR (RVR) and increased VR both in the presence and absence of NE. It was suggested that the decrease in the RVR would be at least partially responsible for the increase in the VR.
No takes yet. Share an insight, caveat, or question.
Kotoo et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: